Additionally, covalent modification of p65 protein caused by DMF subsequently inactivates the NF-κB signal pathway indicating a novel therapeutic strategy in advanced breast cancers (Kastrati et al., 2016). This evidence concerns the gene NFKB1 and breast carcinoma.